Industries & Practices

Health Care Regulatory

Resource Center

HIPAA
Resource Center

More

Federal court sides with Eli Lilly challenge to HHS expansion of 340B discounts

More

Status of MFN drug pricing program remains uncertain

More

CMS releases Hospital 2021 OPPS final rule

More

Health system and physician-owned hospital affiliation

Prepared several options for a health system and physician-owned surgical hospital to affiliate in a secondary market. Provided regulatory advice, including an analysis of potential Stark Law and Anti-Kickback Statute compliance issues, as well as antitrust and federal tax law advice.

More

Change of Ownership RAP appeal

Represented a home health agency in its appeal of post-Medicare Change of Ownership Request for Anticipated Payment suspension imposed by the Centers for Medicare and Medicaid Services. Successfully appealed the payment suspension, which was worth $15 million.

More

Court of appeals rules that HHS has the authority to cut 340B hospitals’ Medicare payments for outpatient drugs by 28.5 percent

More

Behavioral health provider counseling

Represent a variety of behavioral health providers in state licensure matters as well as general operational and compliance matters.

More

Best practices for resolving patient incapacity issues

More

The new price transparency rule: Are you ready?

More

What’s new with drugs?

More

CMS to survey hospitals about acquisition costs for 340B drugs

More